Hantz Financial Services, Inc. Legend Biotech Corp Transaction History
Hantz Financial Services, Inc.
- $5.69 Billion
- Q1 2025
A detailed history of Hantz Financial Services, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 207 shares of LEGN stock, worth $6,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207Holding current value
$6,224% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$208 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$202 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$180 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$172 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$113 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.03B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...